Innate Pharma S.A. (NASDAQ:IPHA) Q2 2025 Earnings Call Transcript September 17, 2025
Innate Pharma S.A. beats earnings expectations. Reported EPS is $-0.2963, expectations were $-0.32845.
Operator: Thank you for standing by, and welcome to the Innate Pharma First Half 2025 Business Update and Financial Results Conference Call. [Operator Instructions]. I’d now like to turn the call over to Stéphanie Cornen, Vice President, Investor Relations and Communications. You may begin.
Stéphanie...
